Vitamin D's Role in Longevity: A Closer Look at Mortality Links
Exploring the link between Vitamin D supplementation and mortality, researchers utilized data from NHANES (2007-2018) to study over 10,000 adults in the U.S. They examined how Vitamin D levels and dosage relate to overall mortality, discovering no significant differences in mortality risk between lower (<800 IU/day) and higher (≥800 IU/day) dosages. However, they found that higher concentrations of Vitamin D in the blood were associated with decreased mortality risks, especially from non-cardiovascular and non-cancer causes.
The analysis delved into various factors influencing Vitamin D levels, such as exposure to sunlight, dietary intake, and genetic predispositions. The study highlights the protective qualities of maintaining adequate Vitamin D levels, proposing potential public health benefits in enhancing Vitamin D status among populations to reduce mortality risks.
This insight into Vitamin D's impact on health and longevity underscores the importance of personalized health strategies. It suggests further research could refine our understanding of optimal Vitamin D levels for health and longevity, offering a clearer path to preventative healthcare.
Article Information
Association Among Vitamin D Supplementation, Serum 25(OH)D Concentrations, and Mortality Risk: A Prospective Cohort Study Using NHANES 2007-2018 Data
Published in Therapeutic Drug Monitoring, Hong Liu et al.
Abstract
Background: To determine the associations among self-reported vitamin D (VD) supplementation, measured serum 25-hydroxyvitamin D (25[OH]D) concentrations, and all-cause and cause-specific mortality risks.
Methods: Self-reported VD supplementation, serum 25(OH)D concentration, and all-cause and cause-specific mortality data from the National Health and Nutrition Examination Survey 2007-2018 were examined for 10,793 adults ≥20 years from the United States. VD dosage was categorized as <800 or ≥800 IU/d. The mortality status and causes of mortality up to 2019 were determined using the National Death Index. The relationships among VD, 25(OH)D levels, and mortality were analyzed using Cox regression before and after propensity score matching (PSM).
Results: Over a median of 6.6 years, 915 deaths were recorded, 230 because of cardiovascular disease (CVD), 240 because of cancer, and 445 because of other specific causes. Mortality risk did not differ between VD <800 IU/d and ≥800 IU/d before or after PSM. However, serum 25(OH)D concentrations were statistically different before and after PSM. The upper 2 quartiles of 25(OH)D levels were associated with lower all-cause mortality, and the fourth quartile was associated with reduced other-specific mortality before and after PSM. No correlation was found between the 25(OH)D concentration and CVD- or cancer-specific mortality after PSM. The inverse 25(OH)D-mortality relationship was consistent across subgroups.
Conclusions: Based on this large cohort study, higher 25(OH)D levels are robustly associated with reduced all-cause and other specific mortality but not CVD- or cancer-specific mortality. These findings support the benefits of maintaining adequate VD status for longevity. Further research is required to elucidate these mechanisms and define the optimal VD concentration to reduce mortality. These results underscore the importance of public health strategies for preventing VD deficiency.
Bring preventive care to your clinic
© Longevity Artificial Intelligence. All rights reserved.